Treprostinil Injection, Solution
Product Images NDC 62332-515

This is a description of a medication, named FEProSUNI. It comes in a 20 mL multidose vial and is recommended for subcutaneous or intravenous infusion only. Each mL of the medication contains 1 mg of treprostinil and 6.3 mg of sodium citrate, along with other ingredients, which are mentioned as well. Users should follow the dosage and administration instructions that come along with the medication. The medication comes with a lot-batch number, expiry date, and manufacturer information.*

Treprostinil Injection is a medication to be used subcutaneously or intravenously that contains 20mg of treprostinil per 20mL. This medication comes in a multi-dose vial and contains sodium citrate, sodium chloride, metacresol, sodium hydroxide, and water for injection. Hydrochloric acid and sodium hydroxide could have been added to adjust pH. It is important to look at the package insert for dosage and administration instructions. The medication should be stored at 25°C (77°F) with excursions permitted at 02.30°C (36-86°F). The product should be kept out of reach of children. The batch number is F.35 and the manufacturing date is 07/2019. The expiry date is not-readable.*

This is a pharmaceutical product with the brand name Treprostinil. It is an Injection with a strength of 200 mg/20 mL (10 mg/mL). It comes in a 20 mL multidose vial and is intended for Subcutaneous or Intravenous Infusion Only. The manufacturing unit is located in Italy and is manufactured by Corden Pharma S.p.A. It is distributed and marketed by Alembic Pharmaceuticals Inc. in Bridgewater, NJ. The product is for prescription use only, and its usual dosage should be obtained from the package insert. The product contains treprosiinil as its main component and also contains other sodium salts like sodium citrate and sodium chloride, water, and other necessary ingredients. Prior to Intravenous Infusion, this product must be diluted, and it should be stored at 25°C (77°F) with excursions permitted to 2-30°C (36-86°F). Keeping it out of the reach of children is mandatory. The given LOT and EXP are specific to the product.*

Treprostinil Injection is a medication that is available in the form of a solution for both subcutaneous and intravenous infusion. Each milliliter of the solution contains 10 mg of treprostinil along with some additional ingredients. The usual dosage should be suggested by healthcare professionals after carefully going through the package insert. Before intravenous infusion, the medication should be diluted. The medication should be stored at room temperature and kept away from children. The details of the batch number, the manufacturing date, and the expiry date are also provided.*

This product is a Treprostinil injection solution with a concentration of 50mg/20mL sold in a multidose vial for subcutaneous or intravenous infusion only. It contains sodium citrate, sodium chloride, metacresol, sodium hydroxide, and Water for Injection. The pH may be adjusted using hydrochloric acid or sodium hydroxide. Before intravenous infusion, the product must be diluted. The usual dosage and administration details can be found in the package insert. The product must be stored at 25°C with excursions permitted to 2-30°C. The lot and batch number, as well as the expiry date, are printed on the label of the product. The product is manufactured for Alembic Pharmaceuticals Inc. located in Bridgewater, NJ, and is manufactured by Corden Pharma S.p.A. in Caponago, Italy.*

Treprostinil Injection is a medication available in a multidose vial containing 50 mg/20 mL (2.5 mg/mL) concentration. It is intended for subcutaneous or intravenous infusion only and requires dilution before administration. Each mL of solution contains 2.5 mg treprostinil, 6.3 mg sodium citrate, 5.3 mg sodium chloride, and 3 mg metacresol along with other inactive ingredients. The usual dosage should be referred to the package insert for administration guidelines. This medication is manufactured by Alembic Pharmaceuticals Inc. and its batch number/date should be carefully monitored.*

This is a description of a medication for the treatment of treprostinil. It is a 100mg/20mL injection, administered through subcutaneous or intravenous infusion only. The medication is contained in a 20mL multidose vial, with storage instructions to keep it at 25°C and out of reach of children. The dosage and administration details are provided in the package insert. The medication is manufactured by Alumbic Pharmaceuticals and contains 5mg treprostinil, along with other compounds. The product must be diluted prior to intravenous infusion. It is an Rx-only medication.*

Treprostinil Injection is a medication administered through subcutaneous or intravenous infusion. It comes in a 20mL vial with a concentration of 5mg/mL, with each mL containing 5mg of treprostinil. Other ingredients included are sodium citrate, sodium chloride, metacresol, sodium hydroxide, and water for injection. The pH may have been adjusted by adding hydrochloric acid and sodium hydroxide. The package insert should be consulted for dosage and administration instructions. The product is manufactured for Alembic Pharmaceuticals Inc. and must be diluted prior to intravenous infusion. The batch number and manufacture date are displayed on the packaging.*